OncoMed Pharmaceuticals Secures $81,600,000 New Funding

  • Feed Type
  • Date
    7/18/2013
  • Company Name
    OncoMed Pharmaceuticals
  • Mailing Address
    800 Chesapeake Drive Redwood City, CA 94063
  • Company Description
    OncoMed Pharmaceuticals (NASDAQ: OMED) is discovering and developing monoclonal antibodies and small molecules capable of destroying cancer stem cells, a recently discovered type of cell believed to seed the growth of cancers and underlie cancer’s ability to spread and take root in tissues.
  • Website
    http://www.oncomed.com
  • Transaction Type
    IPO
  • Transaction Amount
    $81,600,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

By posting a comment, you agree to our terms and conditions.